Evidence map›Paper›PMID 24723845›Full record

ReviewFrontiers in neuroscience2014

Perinatal asphyxia: CNS development and deficits with delayed onset.

Mario Herrera-Marschitz, Tanya Neira-Pena, Edgardo Rojas-Mancilla, Pablo Espina-Marchant, Daniela Esmar, Ronald Perez, Valentina Muñoz, Manuel Gutierrez-Hernandez, Benjamin Rivera, Nicola Simola and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
12.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Prenatal hypoxia in rats increased blood pressure and sympathetic drive of the adult offspring.Hypertension research : official journal of the Japanese Society of Hypertension · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Mario Herrera-MarschitzMillenium Institute BNI-Chile Santiago, Chile ; Department of Molecular and Clinical Pharmacology, ICBM, Medical Faculty, University of Chile Santiago, Chile.
Tanya Neira-PenaMillenium Institute BNI-Chile Santiago, Chile ; Department of Molecular and Clinical Pharmacology, ICBM, Medical Faculty, University of Chile Santiago, Chile ; Department of Chemical-Biological Science, University Bernardo O'Higgins Santiago, Chile.
Edgardo Rojas-MancillaMillenium Institute BNI-Chile Santiago, Chile.
Pablo Espina-MarchantMillenium Institute BNI-Chile Santiago, Chile.
Daniela EsmarDepartment of Molecular and Clinical Pharmacology, ICBM, Medical Faculty, University of Chile Santiago, Chile.
Ronald PerezDepartment of Molecular and Clinical Pharmacology, ICBM, Medical Faculty, University of Chile Santiago, Chile.
Valentina MuñozDepartment of Molecular and Clinical Pharmacology, ICBM, Medical Faculty, University of Chile Santiago, Chile.
Manuel Gutierrez-HernandezMillenium Institute BNI-Chile Santiago, Chile.
Benjamin RiveraDepartment of Molecular and Clinical Pharmacology, ICBM, Medical Faculty, University of Chile Santiago, Chile.
Nicola SimolaDepartment of Biomedical Sciences, Section of Neuropsychopharmacology, Cagliari University Cagliari, Italy.
Diego BustamanteDepartment of Molecular and Clinical Pharmacology, ICBM, Medical Faculty, University of Chile Santiago, Chile.
Paola MoralesDepartment of Molecular and Clinical Pharmacology, ICBM, Medical Faculty, University of Chile Santiago, Chile.
Peter J Gebicke-HaerterDepartment of Molecular and Clinical Pharmacology, ICBM, Medical Faculty, University of Chile Santiago, Chile ; Department of Psychopharmacology, Central Institute of Mental Health J5 Mannheim, Germany.
University of Chile · CLMillennium Institute for Integrative Biology · CLCentral Institute of Mental Health · DEUniversity of Cagliari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perinatal asphyxia constitutes a prototype of obstetric complications occurring when pulmonary oxygenation is delayed or interrupted. The primary insult relates to the duration of the period lacking oxygenation, leading to death if not re-established. Re-oxygenation leads to a secondary insult, related to a cascade of biochemical events required for restoring proper function. Perinatal asphyxia interferes with neonatal development, resulting in long-term deficits associated to mental and neurological diseases with delayed clinical onset, by mechanisms not yet clarified. In the experimental scenario, the effects observed long after perinatal asphyxia have been explained by overexpression of sentinel proteins, such as poly(ADP-ribose) polymerase-1 (PARP-1), competing for NAD(+) during re-oxygenation, leading to the idea that sentinel protein inhibition constitutes a suitable therapeutic strategy. Asphyxia induces transcriptional activation of pro-inflammatory factors, in tandem with PARP-1 overactivation, and pharmacologically induced PARP-1 inhibition also down-regulates the expression of proinflammatory cytokines. Nicotinamide has been proposed as a suitable PARP-1 inhibitor. Its effect has been studied in an experimental model of global hypoxia in rats. In that model, the insult is induced by immersing rat fetus into a water bath for various periods of time. Following asphyxia, the pups are delivered, treated, and nursed by surrogate dams, pending further experiments. Nicotinamide rapidly distributes into the brain following systemic administration, reaching steady state concentrations sufficient to inhibit PARP-1 activity for several hours, preventing several of the long-term consequences of perinatal asphyxia, supporting the idea that nicotinamide constitutes a lead for exploring compounds with similar or better pharmacological profiles.

Indexed as

behaviorcognitiondevelopmentneonatal hypoxic ischemic encephalopathyobstetric complicationsplasticitypoly(ADP-ribose) polymerasesentinel proteins

Identifiers

PMID24723845
PMCPMC3972459
OpenAlexW2051125245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.